← Leaderboards
Thomas Lavstsen
Scripps Research Institute, The
$672,417
Attributed
$2,017,250
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $534.5K · FY2015–18$1M$750K$500K$250K$0
'15
'16
'17
'18
Funding mix
By agency
NIH$2,017,250 · 1
By mechanism
R01$2,017,250 · 1
Top collaborators
- Laurent Olivier Mosnier4 shared
- Hartmut Karl-Heinz Weiler4 shared
Most similar at Scripps Research Institute, The
Same institution · by research overlap
- Laurent Olivier Mosnier$14,213,468
- John Robert Yates$49,942,444
- Hiroshi Deguchi$476,005
Others in their field
Top investigators on “Coagulation Process”
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
- Daniel F Hanley · Johns Hopkins University$44,193,814
- Steven Kyle Grinspoon · Massachusetts General Hospital$22,843,024
- Pamela Susan Douglas · Duke University$22,843,024
- Mortimer Poncz · University Of Pennsylvania$22,637,344
- Carl W White · National Jewish Health$19,202,369
Research focus
Coagulation ProcessContractsCessation Of LifeClassificationActivated Protein C ReceptorComplexAdhesionsAntibodiesAnticoagulantsAdjuvantArtemisininsAttenuatedBaseAdjuvant TherapyAnimal ModelBiochemistryBiologyBlood VesselsBody SystemBrainBypassCell Adhesion MoleculesCellsDesign
Grant awards (4)
Discovery of novel vascular therapies targeting PfEMP1-mediated cytoadhesion in severe malaria$494,250
R01 · FY2018 · HL
Discovery of novel vascular therapies targeting PfEMP1-mediated cytoadhesion in severe malaria$494,250
R01 · FY2017 · HL
Discovery of novel vascular therapies targeting PfEMP1-mediated cytoadhesion in severe malaria$494,250
R01 · FY2016 · HL
Discovery of novel vascular therapies targeting PfEMP1-mediated cytoadhesion in severe malaria$534,500
R01 · FY2015 · HL